SCHEMBL22947486

SCHEMBL22947486

Clc1ccc(-c2ccc3c(c2)[Si](c2cccc4ccccc24)(c2cccc4ccccc24)c2ccccc2-3)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.37
CYP1A1 P04798 4/20 0.37
CYP1B1 Q16678 4/20 0.37
BMX P51813 1/20 0.37
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
PDK2 Q15119 1/20 0.36
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACP3 P15309 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
CDK4 P11802 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947474 0.93 CYP1A2 (0.36) CYP1A2CYP1A1CYP1B1BMXCA12
SCHEMBL27394474 0.88 CYP1A2 (0.45) CYP1A2PDK2EDNRBEDNRAKDM4E
SCHEMBL24166746 0.86 CYP1A2 (0.45) CYP1A2PDK2EDNRBEDNRARAB9A
SCHEMBL22947709 0.86 CYP1A2 (0.41) CYP1A2CYP1A1CYP1B1PDK2KDM4E
SCHEMBL22947659 0.83 MAPT (0.40) CA12CA1CA2CA9KDM4E
SCHEMBL22949335 0.83 MAPT (0.40) CA12CA1CA2CA9KDM4E
SCHEMBL22947558 0.81 ALDH1A1 (0.40) CYP1A2CA12CA1CA2CA9
SCHEMBL22947623 0.80 CYP2A6 (0.41) CYP1A2CA1CA2CA9PDK2
SCHEMBL22947702 0.80 CYP1A2 (0.38) CYP1A2CYP1A1CYP1B1PDK2EDNRB
SCHEMBL6257531 0.79 ALDH1A1 (0.42) CYP1A2CYP1B1KDM4EALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 CYP1A2 281/4885CYP1A1 217/4885CYP1B1 505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.